VIVUS (STU:VIU1) Scaled Net Operating Assets : 0.62 (As of Mar. 2020)

View and export this data going back to . Start your Free Trial

What is VIVUS Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

VIVUS's operating assets for the quarter that ended in Mar. 2020 was €165.66 Mil. VIVUS's operating liabilities for the quarter that ended in Mar. 2020 was €43.43 Mil. VIVUS's Total Assets for the quarter that ended in Dec. 2019 was €196.48 Mil. Therefore, VIVUS's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2020 was 0.62.

VIVUS Scaled Net Operating Assets Historical Data

The historical data trend for VIVUS's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VIVUS Scaled Net Operating Assets Chart

VIVUS Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Scaled Net Operating Assets

Get a 7-Day Free Trial

-0.05

-0.04

0.56

0.48

VIVUS Quarterly Data
	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.48	0.51	0.51	0.62	0.62

Competitive Comparison of VIVUS's Scaled Net Operating Assets

For the Biotechnology subindustry, VIVUS's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

VIVUS's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VIVUS's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where VIVUS's Scaled Net Operating Assets falls into.

VIVUS Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

VIVUS's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2019 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2019 )
=	(Operating Assets (A: Dec. 2019 )	-	Operating Liabilities (A: Dec. 2019 ))	/	Total Assets (A: Dec. 2018 )
=	(167.093	-	39.992)	/	265.587
=	0.48

where

	Operating Assets		(A: Dec. 2019 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	196.477	-	29.384
=	167.093

	Operating Liabilities		(A: Dec. 2019 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	258.779	-	53.391	-	165.396
=	39.992

VIVUS's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2020 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Mar. 2020 )
=	(Operating Assets (Q: Mar. 2020 )	-	Operating Liabilities (Q: Mar. 2020 ))	/	Total Assets (Q: Dec. 2019 )
=	(165.664	-	43.432)	/	196.477
=	0.62

where

	Operating Assets		(Q: Mar. 2020 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	195.397	-	29.733
=	165.664

	Operating Liabilities		(Q: Mar. 2020 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	262.327	-	53.675	-	165.22
=	43.432

VIVUS Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of VIVUS's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

VIVUS (STU:VIU1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VIVUS Inc (STU:VIU1) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

900 East Hamilton Avenue, Suite 550, Campbell, CA, USA, 95008

Website

http://www.vivus.com

VIVUS Inc is a US-based biopharmaceutical company engaged in developing and commercializing, next-generation therapies to address unmet medical needs in human health. Its commercial products include Qsymia, an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index; PANCREAZE which is a is a pancreatic enzyme preparation consisting of pancrelipase, an extract derived from porcine pancreatic glands, as well as other enzyme classes and STENDRA/SPEDRA, which is an oral phosphodiesterase type 5 inhibitor for the treatment of erectile dysfunction.

VIVUS (STU:VIU1) Headlines

No Headlines